Skip to Content

Mitosol Approval History

FDA Approved: Yes (First approved February 7, 2012)
Brand name: Mitosol
Generic name: mitomycin
Dosage form: Ophthalmic Solution
Company: Mobius Therapeutics, LLC
Treatment for: Glaucoma Surgery

Mitosol (mitomycin) is an antimetabolite indicated as an adjunct to ab externo glaucoma surgery.

Development History and FDA Approval Process for Mitosol

DateArticle
Feb  9, 2012Approval Mobius Therapeutics Receives Final FDA Approval for New Glaucoma Drug Mitosol

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide